Health
First Glp-1 Pill For Obesity From Novo Nordisk Launches In The U.s.
By CNBC
Novo Nordisk will start rolling out the first-ever GLP-1 pill for weight loss in the U.S. on Monday, the company announced, marking a new chapter of obesity treatment in the U.S.
The drug's cash prices are among the lowest on the market, ranging from ...Read more
